Histomorphometric effect of six month treatment with oral risedronate in patients with multiple myeloma
- 30 June 1993
- Vol. 14 (3) , 505-509
- https://doi.org/10.1016/8756-3282(93)90187-f
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Relationship between the number of resorbing cells and the amount resorbed in metabolic bone disordersJournal of Bone and Mineral Research, 1991
- Decreased bone formation in osteoporotic patients compared with age-matched controlsCalcified Tissue International, 1989
- Histologic evidence of an abnormal bone remodeling in b-cell malignancies other than multiple myelomaCancer, 1988
- Quantitative histology of myeloma‐induced bone changesBritish Journal of Haematology, 1982
- Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple MyelomaMetabolic Bone Disease and Related Research, 1982
- EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCÆMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASEThe Lancet, 1980